BKMBX
Price
$10.44
Change
+$0.03 (+0.29%)
Updated
Jun 26 closing price
Net Assets
8B
GIMMX
Price
$11.38
Change
-$0.04 (-0.35%)
Updated
Jun 26 closing price
Net Assets
56.42M
Interact to see
Advertisement

BKMBX vs GIMMX

BKMBX vs GIMMX Comparison Chart in %
View a ticker or compare two or three
VS
BKMBX vs. GIMMX commentary
Jun 29, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BKMBX is a Hold and GIMMX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BKMBX has more cash in the bank: 8B vs. GIMMX (56.4M). GIMMX pays higher dividends than BKMBX: GIMMX (7.83) vs BKMBX (2.39). BKMBX was incepted earlier than GIMMX: BKMBX (6 years) vs GIMMX (13 years). GIMMX (2.17) is less costly to investors than BKMBX (0.81). BKMBX is a more actively managed with annual turnover of: 270.00 vs. GIMMX (46.00). GIMMX has a lower initial minimum investment than BKMBX: GIMMX (0) vs BKMBX (5000000). GIMMX annual gain was more profitable for investors over the last year : 13.91 vs. BKMBX (2.48). BKMBX return over 5 years is better than : 18.86 vs. GIMMX (15.74).
BKMBXGIMMXBKMBX / GIMMX
Total Expense Ratio0.810.9486%
Annual Report Gross Expense Ratio0.812.1737%
Fund Existence6 years13 years-
Gain YTD0.7725.07815%
Front LoadN/AN/A-
Min. Initial Investment50000000-
Min. Initial Investment IRAN/AN/A-
Net Assets8B56.4M14,183%
Annual Yield % from dividends2.397.8331%
Returns for 1 year2.4813.9118%
Returns for 3 years20.9919.04110%
Returns for 5 years18.8615.74120%
Returns for 10 yearsN/A37.82-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HLHIX30.380.93
+3.16%
Virtus KAR Health Sciences Inst
GSUTX65.610.06
+0.09%
Goldman Sachs US Equity Insights Inv
MMIJX27.92-0.01
-0.04%
Victory Integrity Mid-Cap Value Member
MINFX39.65-0.09
-0.23%
MFS International Intrinsic Equity R2
JSGTX31.01-0.14
-0.45%
JHancock U.S. Growth R6